Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.
Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine. It is focuses on complex genomic diseases that helps provide clients with the technology for the analysis of genomic sequencing data.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2022 | Series Unknown | $17.49M | — | — | — | Detail |